does bpc 157 help herniated disc bpc-157 for spine What is BPC-157? is a synthetic peptide derived from a protective bpc-157 herniated disc study Stable

These potential benefits make it a compound of interest beyond pure metabolic applications

Whilst injections bypass gut absorption, conditions like active Crohn's disease or coeliac disease may cause increased metabolic demands that could influence how quickly B12 is utilised

Every vial must be discarded after one use, even if water remains inside

BPC/TB-15 is designed primarily for intensive healing phases rather than indefinite long-term use

Dosing Schedules from Published Research Phase 2 Trial Dose Groups The Phase 2 clinical trial published in NEJM employed the following dose groups, all administered via subcutaneous injection once weekly: Scroll sideways to view the full table on mobile

Wait until initial pain and inflammation decrease (typically week 2-3 of treatment) before beginning progressive loading protocols